Report overview
A psychiatric and nervous drug (psychiatric or psychotropic medication) is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.
Mental health and well-being affect our daily lives. Psychotropic medications can be an important part of the tools available to help keep us well.
This report aims to provide a comprehensive presentation of the global market for Psychiatric and Nervous Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychiatric and Nervous Drugs. This report contains market size and forecasts of Psychiatric and Nervous Drugs in global, including the following market information:
Global Psychiatric and Nervous Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Psychiatric and Nervous Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Psychiatric and Nervous Drugs companies in 2022 (%)
The global Psychiatric and Nervous Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antidepressants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psychiatric and Nervous Drugs include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychiatric and Nervous Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychiatric and Nervous Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Type, 2022 (%)
Antidepressants
Anti-anxiety
Antipsychotic
Mood Stabilizing
Stimulant Medications
Others
Global Psychiatric and Nervous Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Psychiatric and Nervous Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychiatric and Nervous Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Psychiatric and Nervous Drugs revenues share in global market, 2022 (%)
Key companies Psychiatric and Nervous Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Psychiatric and Nervous Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Chengdu Kanghong Pharmaceutical
HUAHAI
Zhejiang Jianfeng
Beijing Winsunny Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychiatric and Nervous Drugs, market overview.
Chapter 2: Global Psychiatric and Nervous Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Psychiatric and Nervous Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychiatric and Nervous Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Psychiatric and Nervous Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
